FMP
INVO Bioscience, Inc.
INVO
NASDAQ
Inactive Equity
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
0.833 USD
-0.017 (-2.04%)
Latest INVO News
InvestorPlace
Apr 17, 2024
Why Is Invo Bioscience (INVO) Stock Up 85% Today?
Invo Bioscience (NASDAQ: INVO ) stock is rocketing higher on Wednesday alongside its earnings report for the fourth quarter of 2023. The healthcare services fertility company reported a net loss of $2 million during the quarter.
InvestorPlace
Oct 23, 2023
Why Is INVO Bioscience (INVO) Stock Up 325% Today?
One of the most impressive movers making the most noise in today's session has to be INVO Bioscience (NASDAQ: INVO ). Shares of INVO stock have more than tripled in today's session, surging well more than 325% at the time of writing.
Seeking Alpha
Aug 14, 2023
INVO Bioscience, Inc. (INVO) Q2 2023 Earnings Call Transcript
INVO Bioscience, Inc. (NASDAQ:INVO ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Robert Blum - Investor Relations Steve Shum - Chief Executive Officer Mike Campbell - Chief Operating and Vice President, Business Development Andrea Goren - Chief Financial Officer Operator Good afternoon. And welcome, to the INVO Bioscience Second Quarter Fiscal Year 2023 Financial Results Conference Call.
InvestorPlace
Jun 26, 2023
Why Is INVO Bioscience (INVO) Stock Up 82% Today
INVO Bioscience (NASDAQ: INVO ) stock is on the rise Monday after the company announced a public share offering on Friday. According to a Securities and Exchange Commission (SEC) filing from INVO Bioscience, certain investors may offer up to 6,241,493 shares of INVO stock.
Seeking Alpha
May 15, 2023
INVO Bioscience, Inc. (INVO) Q1 2023 Earnings Call Transcript
INVO Bioscience, Inc. (NASDAQ:INVO ) Q1 2023 Results Conference Call May 15, 2023 4:30 PM ET Company Participants Robert Blum - Lytham Partners Steve Shum - CEO Mike Campbell - Chief Operating Officer and VP of Business Development Andrea Goren - Chief Financial Officer Conference Call Participants Joanne Lee - Maxim Group Rodney Baber - Paulson Investments Operator Good day. And welcome to the INVO First Quarter 2023 Financial Results Conference Call.
Seeking Alpha
Apr 17, 2023
INVO Bioscience, Inc. (INVO) Q4 2022 Earnings Call Transcript
INVO Bioscience, Inc. (NASDAQ:INVO) Q4 2022 Earnings Conference Call April 17, 2023 4:30 PM ET
PRNewsWire
Apr 11, 2023
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023
INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced infertility treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables, will report financial results for its fourth quarter and fiscal year 2022, for the period ended December 31, 2022, after the market close on Monday, April 17, 2023. The Company has scheduled a conference call that same day, Monday, April 17, 2023, at 4:30 pm E...
Pulse2
Mar 25, 2023
INVO Bioscience Announces Pricing of $3 Million Registered Direct Offering Priced At-The-Market
INVO Bioscience announced that it has entered into a securities purchase agreement with a single healthcare-focused institutional investor to buy 3,680,000 shares of common stock. The post INVO Bioscience Announces Pricing of $3 Million Registered Direct Offering Priced At-The-Market appeared first on Pulse 2.0.
PennyStocks
Mar 20, 2023
Best Penny Stocks To Buy? 3 Under $0.99 To Watch Now
Penny stocks under $1 to watch this week. The post Best Penny Stocks To Buy?
Seeking Alpha
Nov 14, 2022
INVO Bioscience, Inc. (INVO) Q3 2022 Earnings Call Transcript
INVO Bioscience, Inc. (NASDAQ:INVO ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Robert Blum - Lytham Partners, IR Steven Shum - Chief Executive Officer Mike Campbell - Chief Operating Officer and VP, Business Development Andrea Goren - Chief Financial Officer Conference Call Participants John Heerdink - Vista Partners LLC Operator Good day. And welcome to the INVO Bioscience Reports on the Third Quarter 2022 Financial Results Call.
